Enhanced adenoviral reactivity in Guillain-Barre syndrome after SARS-CoV-2 infection and vaccination. Bellanti R, Iserte AC, Johnson CB, Goodfellow J, et al. Brain 2025 Oct 7:awaf376. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bellanti R, Iserte AC, Johnson CB, Goodfellow J, et al. Enhanced adenoviral reactivity in Guillain-Barre syndrome after SARS-CoV-2 infection and vaccination. Brain 2025 Oct 7:awaf376. doi: 10.1093.
PMID: 41055073